Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Myeloperoxidase Antikörper (AA 1-193)

MPO Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 9B12G7 unconjugated
Produktnummer ABIN969301
  • Target Alle Myeloperoxidase (MPO) Antikörper anzeigen
    Myeloperoxidase (MPO)
    Bindungsspezifität
    • 16
    • 16
    • 14
    • 14
    • 11
    • 9
    • 8
    • 6
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-193
    Reaktivität
    • 174
    • 64
    • 56
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 132
    • 77
    • 1
    • 1
    • 1
    Maus
    Klonalität
    • 121
    • 91
    Monoklonal
    Konjugat
    • 92
    • 32
    • 30
    • 12
    • 10
    • 10
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser Myeloperoxidase Antikörper ist unkonjugiert
    Applikation
    • 123
    • 85
    • 63
    • 62
    • 33
    • 29
    • 27
    • 19
    • 16
    • 14
    • 14
    • 13
    • 10
    • 8
    • 7
    • 5
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA
    Aufreinigung
    purified
    Immunogen
    Purified recombinant fragment of MPO (aa1-193) expressed in E. coli.
    Klon
    9B12G7
    Isotyp
    IgG1
    Top Product
    Discover our top product MPO Primärantikörper
  • Applikationshinweise
    ELISA: 1:10000, WB: 1:500 - 1:2000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Ascitic fluid containing 0.03 % sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    4°C, -20°C for long term storage
  • Oliveira, Petrilli, Tavela, Zago, de Toledo: "TNF-alpha, TNF-beta, IL-6, IL-10, PECAM-1 and the MPO inflammatory gene polymorphisms in osteosarcoma." in: Journal of pediatric hematology/oncology, Vol. 29, Issue 5, pp. 293-7, (2007) (PubMed).

  • Target
    Myeloperoxidase (MPO)
    Andere Bezeichnung
    Myeloperoxidase (MPO Produkte)
    Synonyme
    mKIAA4033 antikoerper, MPO antikoerper, LOC100335032 antikoerper, POX2' antikoerper, XPOX2' antikoerper, mpo antikoerper, mpo-A antikoerper, pmr-1 antikoerper, pmr1 antikoerper, pox2 antikoerper, xpox2 antikoerper, myeloperoxidase antikoerper, myeloperoxidase L homeolog antikoerper, MPO antikoerper, Mpo antikoerper, LOC100335032 antikoerper, mpo.L antikoerper
    Hintergrund

    Description: Myeloperoxidase (MPO) is a heme protein synthesized during myeloid differentiation that constitutes the major component of neutrophil azurophilic granules. Produced as a single chain precursor, myeloperoxidase is subsequently cleaved into a light and heavy chain. The mature myeloperoxidase is a tetramer composed of 2 light chains and 2 heavy chains. This enzyme produces hypohalous acids central to the microbicidal activity of netrophils.

    Aliases: MPO,myeloperoxidase

    Gen-ID
    4353
    HGNC
    4353
    Pathways
    Chromatin Binding
Sie sind hier:
Kundenservice